123 related articles for article (PubMed ID: 15163306)
1. FSH and LH serum/tumor fluid ratios and malignant tumors of the ovary.
Rzepka-Górska I; Chudecka-Głaz A; Kosmowska B
Endocr Relat Cancer; 2004 Jun; 11(2):315-21. PubMed ID: 15163306
[TBL] [Abstract][Full Text] [Related]
2. Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary.
Chudecka-Głaz A; Rzepka-Górska I; Kosmowska B
Arch Gynecol Obstet; 2004 Nov; 270(3):151-6. PubMed ID: 12883823
[TBL] [Abstract][Full Text] [Related]
3. Gonadotropin levels in ovarian cyst fluids: a predictor of malignancy?
Krämer S; Leeker M; Jäger W
Int J Biol Markers; 1998; 13(3):165-8. PubMed ID: 10079392
[TBL] [Abstract][Full Text] [Related]
4. Luteinizing hormone in peritoneal and ovarian cyst fluids: a predictor of ovarian carcinoma.
Halperin R; Pansky M; Vaknin Z; Zehavi S; Bukovsky I; Schneider D;
Eur J Obstet Gynecol Reprod Biol; 2003 Oct; 110(2):207-10. PubMed ID: 12969585
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropins and female sex steroid hormones in cyst fluid and serum from patients with ovarian tumors.
Thomas CM; Boss EA; Boonstra H; van Tienoven D; Sweep CG; Massuger LF
Eur J Gynaecol Oncol; 2008; 29(5):468-72. PubMed ID: 19051814
[TBL] [Abstract][Full Text] [Related]
6. [The levels of selected hormones in serum and ovarian cyst fluid in girls and young women].
Chudecka-Głaz A; Rzepka-Górska I; Kosmowska B; Głaz C
Ginekol Pol; 1999 May; 70(5):236-41. PubMed ID: 10462955
[TBL] [Abstract][Full Text] [Related]
7. Estradiol, gonadotropins, and tumor markers in ovarian cyst fluid.
Reimer T; Gerber B; Kunkel S; Luettich K
Acta Obstet Gynecol Scand; 1997 May; 76(5):478-83. PubMed ID: 9197453
[TBL] [Abstract][Full Text] [Related]
8. Differential diagnosis of peri- and postmenopausal ovarian cysts.
Reimer T; Gerber B; Müller H; Jeschke U; Krause A; Friese K
Maturitas; 1999 Jan; 31(2):123-32. PubMed ID: 10227005
[TBL] [Abstract][Full Text] [Related]
9. Concentrations of follicle stimulating hormone are increased in ovarian tumor fluid: implications for the management of ovarian cancer.
Chudecka-Głaz A; Rzepka-Górska I
Eur J Gynaecol Oncol; 2008; 29(1):37-42. PubMed ID: 18386461
[TBL] [Abstract][Full Text] [Related]
10. Higher levels of soluble E-cadherin in cyst fluid from malignant ovarian tumours than in benign cysts.
Sundfeldt K; Ivarsson K; Rask K; Haeger M; Hedin L; Brännström M
Anticancer Res; 2001; 21(1A):65-70. PubMed ID: 11299791
[TBL] [Abstract][Full Text] [Related]
11. Endometrioid adenocarcinoma of the ovary mimicking serous borderline tumor: report of a series of cases.
Mansor S; McCluggage WG
Int J Gynecol Pathol; 2014 Sep; 33(5):470-6. PubMed ID: 25083962
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor and its soluble receptor in benign and malignant ovarian tumors.
Artini PG; Ruggiero M; Monteleone P; Carpi A; Cristello F; Cela V; Genazzani AR
Biomed Pharmacother; 2008; 62(6):373-7. PubMed ID: 18037256
[TBL] [Abstract][Full Text] [Related]
13. The Application Value of HNF-1β Transcription Factor in the Diagnosis of Ovarian Clear Cell Carcinoma.
Huang W; Cheng X; Ji J; Zhang J; Li Q
Int J Gynecol Pathol; 2016 Jan; 35(1):66-71. PubMed ID: 26166716
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor in adnexal masses.
Demirkiran F; Kumbak B; Bese T; Arvas M; Benian A; Aydin S; Uzun H; Sanioglu C; Aydinli K; Kösebay D
Int J Gynaecol Obstet; 2003 Oct; 83(1):53-8. PubMed ID: 14511872
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors.
Healy DL; Burger HG; Mamers P; Jobling T; Bangah M; Quinn M; Grant P; Day AJ; Rome R; Campbell JJ
N Engl J Med; 1993 Nov; 329(21):1539-42. PubMed ID: 8413476
[TBL] [Abstract][Full Text] [Related]
16. CA 125 and vascular endothelial growth factor in the differential diagnosis of epithelial ovarian tumors.
Candido Dos Reis F; Moreira de Andrade J; Bighetti S
Gynecol Obstet Invest; 2002; 54(3):132-6. PubMed ID: 12571433
[TBL] [Abstract][Full Text] [Related]
17. Cytopathology of ovarian lesions: the intraoperative approach.
Jiménez-Ayala M; Jiménez-Ayala Portillo B
Monogr Clin Cytol; 2011; 20():60-76. PubMed ID: 21160249
[No Abstract] [Full Text] [Related]
18. Accuracy of intraoperative frozen section for the evaluation of ovarian neoplasms: an institutional experience.
Hashmi AA; Naz S; Edhi MM; Faridi N; Hussain SD; Mumtaz S; Khan M
World J Surg Oncol; 2016 Mar; 14():91. PubMed ID: 27029917
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
[TBL] [Abstract][Full Text] [Related]
20. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]